CEPHAPIRIN SODIUM - Generic Drug Details
What are the generic sources for cephapirin sodium and what is the scope of patent protection?
Cephapirin sodium
is the generic ingredient in two branded drugs marketed by Apothecon, Abraxis Pharm, and Hikma, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Summary for CEPHAPIRIN SODIUM
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 6 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,482 |
| DailyMed Link: | CEPHAPIRIN SODIUM at DailyMed |
Recent Clinical Trials for CEPHAPIRIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for CEPHAPIRIN SODIUM
US Patents and Regulatory Information for CEPHAPIRIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CEPHAPIRIN SODIUM | cephapirin sodium | INJECTABLE;INJECTION | 062720-003 | Jul 2, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | CEFADYL | cephapirin sodium | INJECTABLE;INJECTION | 050446-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | CEFADYL | cephapirin sodium | INJECTABLE;INJECTION | 061769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
